The FDA has issued a recall for more than 11,000 bottles of a blood pressure medication after regulators determined the tablets may not dissolve properly. According to reports, the products were pulled because of a manufacturing error that can affect tablet breakdown, which in turn may reduce how well the medication works as intended. The concern is that if the tablets do not dissolve correctly, patients could receive less effective treatment for high blood pressure. The coverage from multiple outlets describes the recall as affecting a limited number of bottles and emphasizes that the issue relates specifically to dissolution performance rather than an unsafe ingredient. The outlets also note that the recall is intended to prevent patients from using potentially underperforming medication batches. Consumers and patients are advised to follow FDA and distributor instructions for returns, replacement, or other next steps outlined in the recall notice.